You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

Griseofulvin, microsize - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for griseofulvin, microsize and what is the scope of freedom to operate?

Griseofulvin, microsize is the generic ingredient in two branded drugs marketed by Valeant Luxembourg, Actavis Mid Atlantic, Chartwell Rx, Cipla, Cosette, Sandoz Inc, and Sigmapharm Labs Llc, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for griseofulvin, microsize. Five suppliers are listed for this compound.

Summary for griseofulvin, microsize
Pharmacology for griseofulvin, microsize

US Patents and Regulatory Information for griseofulvin, microsize

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sigmapharm Labs Llc GRISEOFULVIN griseofulvin, microsize TABLET;ORAL 202482-001 Oct 22, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Cipla GRISEOFULVIN griseofulvin, microsize SUSPENSION;ORAL 065354-001 Sep 10, 2007 AB RX No No   Start Trial   Start Trial   Start Trial
Actavis Mid Atlantic GRISEOFULVIN griseofulvin, microsize SUSPENSION;ORAL 065394-001 Jul 6, 2007 AB RX No Yes   Start Trial   Start Trial   Start Trial
Chartwell Rx GRISEOFULVIN griseofulvin, microsize SUSPENSION;ORAL 065200-001 Mar 2, 2005 AB RX No No   Start Trial   Start Trial   Start Trial
Sandoz Inc GRISEOFULVIN griseofulvin, microsize TABLET;ORAL 091592-002 Aug 7, 2013 AB RX No Yes   Start Trial   Start Trial   Start Trial
Cosette GRISEOFULVIN griseofulvin, microsize SUSPENSION;ORAL 065438-001 Oct 8, 2010 AB RX No No   Start Trial   Start Trial   Start Trial
Valeant Luxembourg GRIFULVIN V griseofulvin, microsize TABLET;ORAL 062279-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.